|
|
(282 intermediate revisions by 6 users not shown) |
Line 9: |
Line 9: |
| <title></title> | | <title></title> |
| <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.2, user-scalable=yes" /> | | <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.2, user-scalable=yes" /> |
− | <meta name="description" content="Wiki of Peking iGEM 2016" /> | + | <meta name="description" content="Wiki of Peking iGEM 2018" /> |
− | <meta name="author" content="Li Jiamian & Wang Yuqing"/> | + | <meta name="author" content="Peking iGEM"/> |
| <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> | | <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> |
| <!-- Mobile Specific Metas===================================================================== --> | | <!-- Mobile Specific Metas===================================================================== --> |
| <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1"/> | | <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1"/> |
| <!-- Fix Overwrite the original iGEM style=================================================== --> | | <!-- Fix Overwrite the original iGEM style=================================================== --> |
− | <link href="https://2016.igem.org/Template:Peking/css/fix?action=raw&ctype=text/css" rel="stylesheet" /> | + | <link href="https://2018.igem.org/Template:Peking/css/fix?action=raw&ctype=text/css" rel="stylesheet" /> |
| <!-- CSS======================================================================================= --> | | <!-- CSS======================================================================================= --> |
− | <link href="https://2016.igem.org/Template:Peking/css/bootstrap_min?action=raw&ctype=text/css" rel="stylesheet" /> | + | <link href="https://2018.igem.org/Template:Peking/css/bootstrap_min?action=raw&ctype=text/css" rel="stylesheet" /> |
− | <link href="https://2016.igem.org/Template:Peking/css/style?action=raw&ctype=text/css" rel="stylesheet" /> | + | <link href="https://2018.igem.org/Template:Peking/css/style?action=raw&ctype=text/css" rel="stylesheet" /> |
| <!-- CSS======================================================================================= --> | | <!-- CSS======================================================================================= --> |
− | <link rel="stylesheet" href="https://2016.igem.org/Template:Peking/css/default?action=raw&ctype=text/css"/> | + | <link rel="stylesheet" href="https://2018.igem.org/Template:Peking/css/default?action=raw&ctype=text/css"/> |
− | <link rel="stylesheet" href="https://2016.igem.org/Template:Peking/css/layout?action=raw&ctype=text/css"/> | + | <link rel="stylesheet" href="https://2018.igem.org/Template:Peking/css/layout?action=raw&ctype=text/css"/> |
− | <link rel="stylesheet" href="https://2016.igem.org/Template:Peking/css/media-queries?action=raw&ctype=text/css"/> | + | <link rel="stylesheet" href="https://2018.igem.org/Template:Peking/css/media-queries?action=raw&ctype=text/css"/> |
− | <link rel="stylesheet" href="https://2016.igem.org/Template:Peking/css/notebook_panel?action=raw&ctype=text/css"/> | + | <link rel="stylesheet" href="https://2018.igem.org/Template:Peking/css/notebook_panel?action=raw&ctype=text/css"/> |
| <style> | | <style> |
| + | body { background: #D2D8D8 url(https://static.igem.org/mediawiki/2018/7/78/T--Peking--images_bodyBackground.jpeg); background-attachment:fixed;} |
| .texttitle{ | | .texttitle{ |
− | color: #11abb0; | + | color:#6495ED; |
− | font-size: 38px; | + | font-size: 24px; |
| line-height: 48px; | | line-height: 48px; |
| margin-bottom: 12px; | | margin-bottom: 12px; |
Line 38: |
Line 39: |
| padding-top:40px; | | padding-top:40px; |
| } | | } |
| + | <!-- |
| + | .texttitle1{ |
| + | height: 100px; |
| + | color:#6495ED; |
| + | font-size: 24px; |
| + | line-height: 48px; |
| + | margin-bottom: 12px; |
| + | font-family: raleway-bold, sans-serif !important; |
| + | background: transparent; |
| + | letter-spacing: 3px; |
| + | text-transform: uppercase; |
| + | font-weight: 350; |
| + | text-align: center; |
| + | padding-top:40px; |
| + | } |
| + | --> |
| + | |
| sup{font-size:11px;} | | sup{font-size:11px;} |
| .references{margin-top:150px;margin-bottom:40px;} | | .references{margin-top:150px;margin-bottom:40px;} |
Line 188: |
Line 206: |
| width:94%; | | width:94%; |
| float:left; | | float:left; |
| + | margin-left:40px; |
| margin-top:-3px; | | margin-top:-3px; |
| } | | } |
Line 196: |
Line 215: |
| font-style:italic; | | font-style:italic; |
| float:left; | | float:left; |
− | color:#11abb0; | + | color:#1E90FF; |
| opacity:0.8; | | opacity:0.8; |
| } | | } |
Line 216: |
Line 235: |
| </script> | | </script> |
| <!--panel 引用 end ==================--> | | <!--panel 引用 end ==================--> |
| + | |
| | | |
| <!-- Navigation --> | | <!-- Navigation --> |
Line 224: |
Line 244: |
| </a> | | </a> |
| <div id="logo" style="max-width:0px"><a class="" href="https://2018.igem.org/Team:Peking"><img | | <div id="logo" style="max-width:0px"><a class="" href="https://2018.igem.org/Team:Peking"><img |
− | src="https://static.igem.org/mediawiki/2018/e/e2/T--Peking--_toolbar.jpeg" width="45%"></a></div> | + | src="https://static.igem.org/mediawiki/2018/3/36/T--Peking--Logo.png"></a></div> |
| | | |
| <div class="nav-collapse collapse"> | | <div class="nav-collapse collapse"> |
− | <ul class="nav"> | + | <ul class="nav"> |
− | <li class="dropdown menu-1"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >             Project</a> | + | |
| + | <li class="menu-1"><a class="colapse-menu1" href="https://2018.igem.org/Team:Peking">Home</a> |
| + | </li> |
| + | |
| + | <li class="dropdown menu-2"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >Project</a> |
| <ul class="dropdown-menu"> | | <ul class="dropdown-menu"> |
− | <li><a href="https://2018.igem.org/Team:Peking/Project">Project</a></li> | + | <li><a href="https://2018.igem.org/Team:Peking/Project" class="barfont1">Description</a></li> |
− | <li><a href="https://2018.igem.org/Team:Peking/Description" class="barfont1">Description</a></li>
| + | |
| <li><a href="https://2018.igem.org/Team:Peking/Design" class="barfont1">Design</a></li> | | <li><a href="https://2018.igem.org/Team:Peking/Design" class="barfont1">Design</a></li> |
| <li><a href="https://2018.igem.org/Team:Peking/Demonstrate" class="barfont1">Demonstration</a></li> | | <li><a href="https://2018.igem.org/Team:Peking/Demonstrate" class="barfont1">Demonstration</a></li> |
− | <li><a href="https://2018.igem.org/Team:Peking/Future_Plan" class="barfont1">Future Plan</a></li> | + | <li><a href="https://2018.igem.org/Team:Peking/Perspective" class="barfont1">Perspective</a></li> |
| </ul> | | </ul> |
| </li> | | </li> |
− | <li class="dropdown menu-2"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >Data Page</a> | + | <li class="menu-3"><a class="colapse-menu1" href="https://2018.igem.org/Team:Peking/Model">Modeling</a> |
− | <ul class="dropdown-menu">
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Results">Data Page</a></li>
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Phase_Separation_D" class="barfont1">Phase Separation</a></li>
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Functions_D" class="barfont1">Functions</a></li>
| + | |
− | </ul>
| + | |
| </li> | | </li> |
− | <li class="dropdown menu-3"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >Model</a> | + | <li class="menu-4"><a class="colapse-menu1" href="https://2018.igem.org/Team:Peking/Software">Software</a> |
− | <ul class="dropdown-menu">
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Model">Model</a></li>
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Phase_Separation_M" class="barfont1">Phase Separation</a></li>
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Functions_M" class="barfont1">Functions</a></li>
| + | |
− | </ul>
| + | |
| </li> | | </li> |
− | <li class="menu-4"><a class="colapse-menu1" href="https://2018.igem.org/Team:Peking/Software" >Software</a> | + | |
| + | |
| + | <li class="menu-6"><a class="colapse-menu1" href="https://2018.igem.org/Team:Peking/Human_Practices">Human Practices</a> |
| </li> | | </li> |
− | <li class="dropdown menu-5"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >Human Practices</a>
| + | <li class="dropdown menu-7"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >Achievement</a> |
− | <ul class="dropdown-menu">
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Human_Practices/Gold" class="barfont1">Human Practices</a></li>
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Public_Engagement" class="barfont1">Public Engagement</a></li>
| + | |
− | </ul>
| + | |
− | </li>
| + | |
− | <li class="dropdown menu-6"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >Team</a> | + | |
| <ul class="dropdown-menu"> | | <ul class="dropdown-menu"> |
− | <li><a href="https://2018.igem.org/Team:Peking/Team_Members" class="barfont1">Team Members</a></li> | + | <li><a href="https://2018.igem.org/Team:Peking/Judging_Form" class="barfont1">Judging Form</a></li> |
− | <li><a href="https://2018.igem.org/Team:Peking/Attributions" class="barfont1">Attributions</a></li> | + | <li><a href="https://2018.igem.org/Team:Peking/Parts" class="barfont1">Parts</a></li> |
− | <li><a href="https://2018.igem.org/Team:Peking/Safety" class="barfont1">Safety</a></li> | + | <li><a href="https://2018.igem.org/Team:Peking/Improve" class="barfont1">Improvement</a></li> |
− | <li><a href="https://2018.igem.org/Team:Peking/Notebook" class="barfont1">Notebook</a></li> | + | <li><a href="https://2018.igem.org/Team:Peking/InterLab" class="barfont1">InterLab</a></li> |
| + | |
| </ul> | | </ul> |
| </li> | | </li> |
− | <li class="dropdown menu-7"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >Collaborations</a> | + | <li class="dropdown menu-8"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >Lab</a> |
| <ul class="dropdown-menu"> | | <ul class="dropdown-menu"> |
| + | <li><a href="https://2018.igem.org/Team:Peking/Team_Members">Team Members</a></li> |
| + | <li><a href="https://2018.igem.org/Team:Peking/Attributions" class="barfont1">Attributions</a></li> |
| + | <li><a href="https://2018.igem.org/Team:Peking/Notebook" class="barfont1">Notebook</a></li> |
| <li><a href="https://2018.igem.org/Team:Peking/Collaborations" class="barfont1">Collaborations</a></li> | | <li><a href="https://2018.igem.org/Team:Peking/Collaborations" class="barfont1">Collaborations</a></li> |
| + | <li><a href="https://2018.igem.org/Team:Peking/Safety" class="barfont1">Safety</a></li> |
| <li><a href="https://2018.igem.org/Team:Peking/Acknowledgement" class="barfont1">Acknowledgement</a></li> | | <li><a href="https://2018.igem.org/Team:Peking/Acknowledgement" class="barfont1">Acknowledgement</a></li> |
− | <li><a href="https://2018.igem.org/Team:Peking/InterLab" class="barfont1">InterLab</a></li> | + | |
− | </ul>
| + | |
− | </li>
| + | |
− | <li class="dropdown menu-8"><a class="dropdown-toggle" data-toggle="dropdown" href="#" >Parts</a>
| + | |
− | <ul class="dropdown-menu">
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Parts">Parts</a></li>
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Favorite_Parts" class="barfont1">Favorite Parts</a></li>
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Part_Table" class="barfont1">Part Table</a></li>
| + | |
− | <li><a href="https://2018.igem.org/Team:Peking/Part_Collection" class="barfont1">Part Collection</a></li>
| + | |
| </ul> | | </ul> |
| </li> | | </li> |
Line 293: |
Line 299: |
| <div class="row"> | | <div class="row"> |
| <div class="twelve columns centered text-center"> | | <div class="twelve columns centered text-center"> |
− | <h1>Demonstrate</h1> | + | <h1>Demonstration</h1> |
| <p class="title1" style="text-align:center">In this section, you could see the demonstration.</p> | | <p class="title1" style="text-align:center">In this section, you could see the demonstration.</p> |
| </div> | | </div> |
Line 311: |
Line 317: |
| <div id="page-wrap"> | | <div id="page-wrap"> |
| <div id="sidebar" style="color:#000000"> | | <div id="sidebar" style="color:#000000"> |
− | <h4><a href="javascript:void(0);" onclick="naver('A')">To A</a></h4> | + | <h4><a href="javascript:void(0);" onclick="naver('A')">•Overview</a></h4> |
− | <h4><a href="javascript:void(0);" onclick="naver('B')">To B</a></h4> | + | <h4><a href="javascript:void(0);" onclick="naver('B')">•SponSPOT</a></h4> |
| <ul> | | <ul> |
− | <li><a href="javascript:void(0);" onclick="naver('B1')">Theoretical Deduction</a></li> | + | <li><a href="javascript:void(0);" onclick="naver('B1')">Formation</a></li> |
− | <li><a href="javascript:void(0);" onclick="naver('B2')">Scaffold Construction</a></li> | + | <li><a href="javascript:void(0);" onclick="naver('B2')">Liquid−like Properties</a></li> |
| + | <li><a href="javascript:void(0);" onclick="naver('B3')">Control Method</a></li> |
| + | </ul> |
| + | <h4><a href="javascript:void(0);" onclick="naver('C')">•RapaSPOT</a></h4> |
| + | <ul> |
| + | <li><a href="javascript:void(0);" onclick="naver('C1')">Formation</a></li> |
| + | <li><a href="javascript:void(0);" onclick="naver('C2')">Toxicity of Rapamycin</a></li> |
| + | <li><a href="javascript:void(0);" onclick="naver('C3')">Kinetics</a></li> |
| + | </ul> |
| + | <h4><a href="javascript:void(0);" onclick="naver('Z')">•Functions</a></h4> |
| + | <ul> |
| + | <li><a href="javascript:void(0);" onclick="naver('D1')">Organization</a></li> |
| + | <li><a href="javascript:void(0);" onclick="naver('D2')">Sensor</a></li> |
| + | <li><a href="javascript:void(0);" onclick="naver('D3')">Reaction Hub</a></li> |
| </ul> | | </ul> |
− | <h4><a href="javascript:void(0);" onclick="naver('C')">To C</a></h4>
| |
− | <h4><a href="javascript:void(0);" onclick="naver('D')">To C</a></h4>
| |
| </div> | | </div> |
| </div> | | </div> |
Line 328: |
Line 345: |
| <div class="nine columns"> | | <div class="nine columns"> |
| | | |
− | <a id="A"></a> | + | <div class="texttitle"><a id="A"></a>Overview |
− | <div class="texttitle">Overview</div>
| + | </div> |
− | <br/> | + | <hr style="border:2px dashed; height:2px" color="#666666"> |
| + | |
| <div class="coll"> | | <div class="coll"> |
| | | |
| <div class="content"> | | <div class="content"> |
− | <p>The aim of our project is to build a synthetic organelle based on phase separation as a multifunctional platform. Based on the principle of multivalence and interaction, we fused interactional modules into homo-oligomeric tags (HOtags) to form granules in S. cerevisiae.</p> | + | <p>The aim of our project is to build a synthetic organelle based on phase separation as a multifunctional platform. Based on the principle of multivalence and interaction, we fused interactional modules into homo-oligomeric tags (HOTags) to form granules in S. cerevisiae. (Click to see more about <a href="https://2018.igem.org/Team:Peking/Project_overview">Description</a> and <a href="https://2018.igem.org/Team:Peking/Design">Design</a>)</p> |
| </div> | | </div> |
| </div> | | </div> |
Line 346: |
Line 364: |
| | | |
| <div class="content"> | | <div class="content"> |
− | <p>It inspired us to propose some specific applications of our synthetic organelles, including organization hub, sensor, and metabolism regulator. We have verified the feasibility of them by loading GFP-nanobody module, NAD+ sensor module and carotene production module to the whole system.</p> | + | <p>It inspired us to propose some specific applications of our synthetic organelles, including organization hub, sensor, and metabolism regulator. We have verified the feasibility of them by loading GFP-nanobody module, ABA sensor module and carotene production module to the whole system.</p> |
| </div> | | </div> |
| </div> | | </div> |
Line 352: |
Line 370: |
| | | |
| <div class="content"> | | <div class="content"> |
− | <p>We believe that our work has reached the medal requirements of demonstration as we have confirmed that our synthetic organelles can be formed in vivo and deliver a range of functions both for engineering and research due to their amazing properties. The concrete demonstration of the whole platform is shown below. You can see more details of experiments and modeling in our <a href="https://2018.igem.org/Team:Peking/Results"/>Data Page</a> and <a href="https://2018.igem.org/Team:Peking/Model"/>Modeling</a></p> | + | <p>We believe that our work has reached the medal requirements of demonstration as we have confirmed that our synthetic organelles can be formed in vivo and deliver a range of functions both for engineering and research due to their amazing properties. The concrete demonstration of the whole platform is shown below. You can see more details of experiments and modeling in our <a href="https://2018.igem.org/Team:Peking/Notebook">Notebook</a> and <a href="https://2018.igem.org/Team:Peking/Model">Modeling</a></p> |
| </div> | | </div> |
| </div> | | </div> |
| | | |
− | <br/>
| + | |
| | | |
− | <div class="texttitle">Phase Separation System | + | <div class="texttitle"><br/><a id="B"></a>Spontaneous SPOT(SUMO-SIM mediated) |
− | <a id="B"></a></div> | + | </div> |
| + | <hr style="border:2px dashed; height:2px" color="#1E90FF"> |
| <div class="coll"> | | <div class="coll"> |
− | <div class="info">
| + | |
− | <a id="B1"></a>
| + | |
− | <div class="ordi">1.</div>
| + | |
− | </div>
| + | |
| <div class="content"> | | <div class="content"> |
− | <h3>Spontaneous and induced synthetic organelles can be formed by phase separation</h3> | + | <p>To achieve the aim of building a phase-separation based on synthetic organelle platform(SPOT), we must verify that granules can be formed by phase separation in our design. We have used several modules to build different phase separation based organelles and characterize their properties well so we believe that these organelles can perform functions well in proper situations.</p> |
| </div> | | </div> |
| </div> | | </div> |
Line 373: |
Line 390: |
| | | |
| <div class="content"> | | <div class="content"> |
− | <p>Our basic system consists of two components of synthetic organelles. Either of them has a specific HOtag to form homo-oligomers. We expect that they are able to form synthetic organelles due to the principles of phase separation. To verify the feasibility of the design, we fused two fluorescence proteins with the two components of synthetic organelles (Figure1.a) so that we can observe the self-organization of components and the formation of granules under fluorescence microscope.</p> | + | <h3><a id="B1"></a>1.A spontaneous organelle can be formed with HOTags and SUMO-SIM interaction module</h3> |
| </div> | | </div> |
| </div> | | </div> |
Line 380: |
Line 397: |
| | | |
| <div class="content"> | | <div class="content"> |
− | <p>We used SUMO-SIM interaction module to build a spontaneous organelle. When two components are expressed in yeasts, granules with the two fluorescence proteins can be observed in vivo (Figure1.b). </p> | + | <p>We designed a spontaneous phase separation system with SUMO-HOTag3 and SIM-HOTag6 to form synthetic organelles. Modification of proteins by SUMO are recognized by SUMO-interacting motifs termed SIMs (Fig .1A). So SUMO and SIM can combine spontaneously to drive the phase separation process. To verify this design, we constructed yeast strains, that were genomically transferred with SUMO-yEGFP-HOTag3 and SIM-mCherry-HOTag6 (Fig .1B). We observed that granules via the two fluorescence signals, which occurred spontaneously in most yeasts cells under microscope. The images of GFP and mCherry channels merged well, which confirms that the SPOT consists of the two components as we expect(Fig. 1C).</p> |
| + | |
| + | <div align="center"><img src="https://static.igem.org/mediawiki/2018/b/b0/T--Peking--Demof1.gif"> |
| + | </div> |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;"> |
| + | Figure. 1A Structure of SUMO3 and SIM. SIMs bind to a surface patch between the α-helix and a β-sheet of the SUMO protein and extend the β-sheet of SUMO by one additional strand. The SIM either attaches as a parallel or an antiparallel strand to the SUMO β-sheet. Binding is primarily mediated by a stretch of four residues containing 3–4 hydrophobic amino acids (I, V, or L). This core interaction motif is a common property of SIMs.<br/> |
| + | Figure. 1B Pattern diagram of SUMO-yEGFP and SIM-mCherry. yEGFP is fused to the C-terminus of SUMO and to the N-terminus of HOTag3, mCherry is fused to the C-terminus of SIM and to the N-terminus of HOTag6.<br/> |
| + | Figure. 1C Localization of SUMO-yEGFP and SIM-mCherry. yEGFP is fused to the C-terminus of SUMO and to the N-terminus of HOTag3, mCherry is fused to the C-terminus of SIM and to the N-terminus of HOTag6. Both are under the control of constitutive promoters. Localization of red granules and green granules can be detected under fluorescence microscope. Arrow points to localization of red and green granules. |
| + | <br/> |
| + | <br/></div> |
| + | </figcaption> |
| + | <br/> |
| + | <br/> |
| + | <br/> |
| + | <br/> |
| + | |
| + | <br/> |
| + | <br/> |
| + | |
| + | |
| + | |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | <h3><a id="B2"></a>2.SPOT are spherical and liquid-like droplets </h3> |
| </div> | | </div> |
| </div> | | </div> |
Line 387: |
Line 427: |
| | | |
| <div class="content"> | | <div class="content"> |
− | <p>Meanwhile, by rapamycin induced interaction module, FKBP-Frb, we have built an inducible organelle. We can see granules occurs in yeasts within minutes after adding the inducer.</a> </p> | + | <p>We wondered whether our synthetic organelles are liquid-like or not. A liquid-like granule is in a more dynamic state, exchanges mass with cytoplasm frequently and then responses to environment rapidly. And the liquid-like property makes organelles more controllable. Moreover, potential function modules perform may perform normally only in a droplet. It’s necessary to find out whether our SPOT were liquid-like or not. </p> |
| </div> | | </div> |
− | Figure1.a The basic design of synthetic organelles with florescence reporters. (这里可能需要一张cartoon的设计图)
| + | </div> |
− | b, c fluorescence images of spontaneous organelles (SUMO-SIM based) and inducible synthetic organelles (FKBP-Frb based, after adding 10000 nM rapamycin)
| + | |
| + | <div class="coll"> |
| | | |
| + | <div class="content"> |
| + | <p>Due to surface tension, a liquid-like droplet should be spherical and can go through rapid rearrangement in FRAP (Fluorescence Recovery After Photo-bleaching).</p> |
| + | </div> |
| </div> | | </div> |
| | | |
| + | <div class="coll"> |
| | | |
| + | <div class="content"> |
| + | <p>The 3D-rendered shape of the granules was recorded using a confocal microscope, which showed that the granules are nearly spherical. (Fig .2A) Meanwhile, we used FRAP to measure the rearrangement properties the granule(Fig .2B). After fluorescence quenching, the fluorescence of granules showed a rapid mass exchange which indicates that the granules have rapid mass exchange with the cytoplasm and resemble liquid-like droplets(Fig .2C).</p> |
| + | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | <div align="center"><img src="https://static.igem.org/mediawiki/2018/d/de/T--Peking--Demof2.png"> |
| + | </div> |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;"> |
| + | Figure. 2A Confocal microscopy images of SPOT consisting of SUMO-HOTag3 and SIM-HOTag6. The shape is nearly spherical. |
| + | <br/> |
| + | Figure. 2B The recovery of fluorescence in SPOT was monitored in FRAP (Fluorescence Recovery After Photo-bleaching). After photobleaching, fluorescence recoveries in eight seconds. Arrow points to photobleaching site. Images were taken for~1min.Scalebar is 1.70μm per unit. |
| + | <br/> |
| + | Figure. 3C Normalized intensity of FRAP. After photobleaching, the fluorescence of droplet1 recoveries about 80% and the fluorescence of droplet2 recoveries about 50%. They both recoveries in about 20 seconds. |
| + | <br/> |
| + | <br/> |
| + | </figcaption> |
| + | </div> |
| + | <div align="center"> |
| + | <img src="https://static.igem.org/mediawiki/2018/9/9d/T--Peking--DemoM1.gif"><br/> |
| + | <div class="content"> |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;">Movie. 1 3D-rendered images of SPOT consisting of SUMO-HOTag3 and SIM-HOTag6. The shape is nearly spherical. |
| + | <br/> |
| + | <br/> |
| + | </figcaption > |
| + | </div> |
| + | </div> |
| + | </div> |
| + | </div> |
| <div class="coll"> | | <div class="coll"> |
− | <div class="info">
| + | <div class="content"> |
− | <a id="B2"></a>
| + | <h3><a id="B3"></a>3.SPOT can be controlled by regulating the expression level of components</h3> |
− | <div class="ordi"><br/>2.</div>
| + | |
| </div> | | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | |
| <div class="content"> | | <div class="content"> |
− | <h3>The formation of organelles has flexible but predictable properties and kinetics in different conditions</h3> | + | <p>Then we designed a dox-induced synthetic organelle by using Tet07 promoter. To design a dox-inducible SPOT, we constructed strains with SUMO-yEGFP-HOTag3 and SIM-mCherry-HOTag6, while only the later one was controlled by TetO7 promoter(Fig .3). In a dox-induction experiment, we observed that after adding dox, the concentration of SIM-mCherry-HOTag6 fusion proteins increased gradually and granules appeared relatively abruptly and became larger in the following time. Quantitative analysis of the fluorescence movie was in agreement with the result. Thus, the formation of our SPOT can be controlled at the transcription level, which made us wonder if our synthetic organelles can be coupled with a certain genetic circuit to perform complex functions in cells.</p> |
| </div> | | </div> |
| </div> | | </div> |
| + | |
| + | <div align="center"><img src="https://static.igem.org/mediawiki/2018/1/15/T--Peking--Demof3.png"> |
| + | </div> |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;"> |
| + | Figure. 3A Construction of SUMO-yEGFP and SIM-mCherry to prove phase separation can be regulated at the level of gene expression. SUMO-yEGFP is under the control of a constitutive promoter and SIM-mCherry is under the control of Tet07 promoter, an inducible promoter, which can be induced by doxcycline(Dox). |
| + | <br/> |
| + | Figure. 3B Time-lapse fluorescence images of phase separation regulated at the level of gene expression. Before adding dox, only green fluorescence can be detected and it covers the entire cell. After adding dox for 5 hours, localization of red droplet and green droplet can be detected. Arrow points to localization of red and green droplets. Images were taken for ~ 7hr.Scalebar,30μm. |
| + | <br/> |
| + | Figure. 3C Fluorescence intensity of SUMO-yEGFP and SIM-mCherry, proportion of cells with SPOT. In a repeat experiment, after adding dox, red fluorescence intensity increases with time. What’s more, after the expression of SIM-mCherry, proportion of cells with SPOT increases well in about 3 hours. |
| + | </figcaption > |
| + | </div> |
| + | </div> |
| + | |
| + | <div align="center"> |
| + | <div class="texttitle"><a id="C"></a>Controllable Rapamycin-induced SPOT (FKBP-Frb mediated)</div> |
| + | </div> |
| + | <hr style="border:2px dashed; height:2px" color="#1E90FF"> |
| | | |
| <div class="coll"> | | <div class="coll"> |
| | | |
| <div class="content"> | | <div class="content"> |
− | <p>Then we combined <a href="https://2018.igem.org/Team:Peking/Phase_Separation_M"/>modeling of phase separation</a> and experiment to research the kinetics of the organelles formation process expecting that a well-characterized system can reach its whole potential in complex applications. </p> | + | <h3><a id="C1"></a>1.Rapid control of organelles can be achieved by using chemical-induced module like FKBP and Frb</h3> |
| </div> | | </div> |
| </div> | | </div> |
Line 415: |
Line 513: |
| | | |
| <div class="content"> | | <div class="content"> |
− | <p>We used SUMO-SIM interaction module to build a spontaneous organelle. When two components are expressed in yeasts, granules with the two fluorescence proteins can be observed in vivo (Figure1.b). </p> | + | <p>Through the time-lapse fluorescence video results, we noticed there was a great time delay of gene expression, usually about several hours. To make our SPOT system response to environment rapidly, we designed an inducible SPOT which relies on FKBP-rapamycin-Frb system, short as RapaSPOT. FKBP and Frb can combine together in the presence of rapamycin(Fig .4A). We constructed strains with FKBP-mCherry-HOTag3 and Frb-yEGFP-HOTag6 and used 10 μM rapamycin to induce the RapaSPOT formation. Minutes after adding rapamycin, granules appeared and became larger gradually(Fig .4B,4C). The merge images of granules confirmed that the granules consisted of both components as we expect.</p> |
| + | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | <h3><a id="C2"></a>2.The toxicity of inducer will not affect SPOT much</h3> |
| </div> | | </div> |
| </div> | | </div> |
Line 422: |
Line 526: |
| | | |
| <div class="content"> | | <div class="content"> |
− | <p>Meanwhile, by rapamycin induced interaction module, FKBP-Frb, we have built an inducible organelle. We can see granules occurs in yeasts within minutes after adding the inducer.</a> </p> | + | <p>Rapamycin induced phase separation can make the synthetic organelles controllable at protein level. However, rapamycin is a typical antifungal which is toxic to yeast, since its complex with FKBP will activate the TOR pathway and the cell cycle will be arrested in G1. So what will happen when rapamycin is 'blocked' in our phase separation system? We assume that this effect is strong enough to prevent yeast cell death so that rapamycin induction can be applied in bioengineering.</p> |
| </div> | | </div> |
− | Figure1.a The basic design of synthetic organelles with florescence reporters. (这里可能需要一张cartoon的设计图)
| + | </div> |
− | b, c fluorescence images of spontaneous organelles (SUMO-SIM based) and inducible synthetic organelles (FKBP-Frb based, after adding 10000 nM rapamycin)
| + | |
| + | <div class="coll"> |
| | | |
| + | <div class="content"> |
| + | <p>We measured the cell growth curves with the two strains: yeasts with both FKBP-mCherry-HOTag3 and Frb-yEGFP-HOTag6 and wild type yeasts with different concentrations of rapamycin as control group(Fig .4D). The results show that wild-type yeast cannot grow and reproduce normally in the presence of rapamycin, while the yeast with both FKBP-mCherry-HOTag3 and Frb-yEGFP-HOTag6, which can form SPOT, could still grow, especially in a relatively low concentration of rapamycin. We then observed the cells that had been treated with rapamycin for 12 hours under the microscope and confirmed that the yeast cells are in good condition and the synthetic organelles didn’t disappear. Therefore, we believe that the design of RapaSPOT is feasible, and sequestration is a potential function for SPOT.</p> |
| + | </div> |
| </div> | | </div> |
| | | |
− | | + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <div align="center"> |
| + | <img src="https://static.igem.org/mediawiki/2018/9/97/T--Peking--Demof4.png"><br/> |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;">Figure. 4 Chemical-induced SPOT can be formed by using rapamycin to induce FKBP-Frb interactions<br/> |
| + | Figure. 4A The structure of FKBP and Frb. Rapamycin can induce the interaction between them. |
| + | <br/> |
| + | Figure. 4B Design of RapaSPOT. FKBP is fused with mCherry and HOTag3 while Frb is fused with yEGFP and HOTag6. After adding rapamycin, they are expected to self-organize to form large assemblies, which will be an organelle in cells. |
| + | <br/> |
| + | Figure. 4C Granules in chemical-induced SPOT after adding rapamycin. Ura3-FKBP-HOTag3(mCherry) and PDH3-Frb-HOTag6 with yEGFP are transferred and expressed in S. cerevisiae. Fluorescence images in both GFP and mCherry channels of cells are taken after the addition of 10 μM rapamycin. Granules occurs in less than 20 minutes (see Movie2) and the two fluorescence channels merge well.<br/> |
| + | Figure. 4D Growth curves of wild-type yeasts (black curve) and yeast strains with Ura3-FKBP-HOTag3 and PDH3-Frb-HOTag6 (red curve). They are measured after adding different concentration of rapamycin for 24 hours. Wild-type yeasts cannot grow and reproduce normally while engineered yeasts with FKBP-HOTag3 and Frb-HOTag6 can survive when exposed to rapamycin. |
| + | |
| + | <br/> |
| + | <br/> |
| + | </figcaption > |
| + | </div> |
| + | <div align="center"> |
| + | <table border="0"> |
| + | <tr> |
| + | <th><img src="https://static.igem.org/mediawiki/2018/0/04/T--Peking--DemoM3c.gif"></th> |
| + | <th><img src="https://static.igem.org/mediawiki/2018/9/9b/T--Peking--DemoM2b.gif"></th> |
| + | </tr> |
| + | <tr> |
| + | <th>greyscale</td> |
| + | <th>GFP</td> |
| + | </tr> |
| + | <tr> |
| + | <th><img src="https://static.igem.org/mediawiki/2018/9/93/T--Peking--DemoM2c.gif"></th> |
| + | <th><img src="https://static.igem.org/mediawiki/2018/8/8b/T--Peking--DemoM2d.gif"></th> |
| + | </tr> |
| + | <tr> |
| + | <th>mCherry</td> |
| + | <th>merge</td> |
| + | </tr> |
| + | <tr> |
| + | <th colspan="2">Movie. 2 The formation process of chemical-induced SPOT after adding rapamycin. Granules occurs in less than 20 minutes and the two fluorescence channels merge well. |
| + | </td> |
| + | </tr> |
| + | </table> |
| + | <br/> |
| + | |
| + | </div> </div> |
| + | </div> |
| | | |
− |
| |
− | <a id="C"></a>
| |
− | <div class="texttitle">Our future plan</div>
| |
− | <br/>
| |
| <div class="coll"> | | <div class="coll"> |
− | <div class="info">
| + | <div class="content"> |
− | <div class="ordi">1.</div> | + | <h3><a id="C3"></a>3.Different concentration of components and rapamycin vary the kinetics of phase separation</h3> |
| </div> | | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | |
| <div class="content"> | | <div class="content"> |
− | <p>We should reproduce all of the experiments that we have done this summer to make sure the results are credible.</p> | + | <p>As our <a href="https://2018.igem.org/Team:Peking/Model">Modeling</a> work predicts, the kinetics of a system depends on the concentration of the components and the interaction strength(Fig .5A). By verifying these theoretical predictions by experiment, we have made our SPOT a more tunable and modularized system for applications.</p> |
| </div> | | </div> |
| </div> | | </div> |
| | | |
| <div class="coll"> | | <div class="coll"> |
− | <div class="info"> | + | |
− | <div class="ordi">2.</div> | + | <div class="content"> |
| + | <p>The kinetics of SPOT system depend on the concentrations of components. The concentration can be regulated by controlling the gene expression level of components, so we design a 3*3 promoters combinations in our RapaSPOT to research some principles for engineering. Ura3, TEF1, and PDH3 were chosen to provide concentration gradient and their strength was measured by flow cytometry(Fig .5B). The interaction between FKBP and Frb was induced by 10μM rapamycin and observations of aggregates were conducted under fluorescence microscope since all the components are fused with yEGFP. We found that the aggregates appeared only when FKBP-HOTags were expressed at a low level of Frb-HOTags were at a high level, which fit our simulation well.</p> |
| </div> | | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | |
| <div class="content"> | | <div class="content"> |
− | <p>We will optimize the whole strategy to enhance the adsorption efficiency by changing pH, temperature, reaction time of crosslinking and clearance. (The efficiency is only about 60% without further optimization)</p> | + | <p>Another variable which could affect the SPOT formation significantly is the strength of interaction between two components. In RapaSPOT, it means the concentration of rapamycin, which will affect the apparent affinity of FKBP and Frb. We conducted a rapamycin gradient induction experiment to investigate the kinetics. Yeast Strains with FKBP-mCherry-HOTag3 and Frb-yEGFP-HOTag6 were induced by rapamycin from 0.01 to 100μM. We found that higher concentration of rapamycin could induce faster SPOT formation which fit our model well(Fig .5D). At the same time, we had to notice that if the concentration of rapamycin is too high, the SPOT formation process will be restrained.</p> |
| </div> | | </div> |
| </div> | | </div> |
| | | |
| <div class="coll"> | | <div class="coll"> |
− | <div class="info"> | + | |
− | <div class="ordi">3.</div>
| + | <div class="content"> |
| + | <div align="center"> |
| + | <img src="https://static.igem.org/mediawiki/2018/d/d8/T--Peking--Demof5.png"><br/> |
| + | <div> |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;"> |
| + | Figure. 5A The formation of SPOT can be described as a phase separation process of three components. Two important variable, the concentration of components and the interaction strength are marked in the figure. |
| + | <br/> |
| + | Figure. 5B Flow Cytometry results of three promoters (Ura3, Tef2, and PDH3). The expression level of Ura3 is lowest while PDH3 is the strongest promoter. |
| + | <br/> |
| + | Figure. 5C RapaSPOT of different promoter combinations after 10 μM rapamycin induction. Two axes stand for the expression level of components. After 3 hours, Only SPOT system with high level of Frb can be observed. |
| + | <br/> |
| + | Figure. 5D Proportion of yeasts with granules after rapamycin induction. The rapamycin is from 1μM to 100 μM. |
| + | </figcaption> |
| + | <table border="0"> |
| + | <tr> |
| + | <th><img src="https://static.igem.org/mediawiki/2018/1/1f/T--Peking--DemoM3a.gif"></th> |
| + | <th><img src="https://static.igem.org/mediawiki/2018/5/58/T--Peking--DemoM3b.gif"></th> |
| + | <th><img src="https://static.igem.org/mediawiki/2018/0/04/T--Peking--DemoM3c.gif"></th> |
| + | <th><img src="https://static.igem.org/mediawiki/2018/6/6f/T--Peking--DemoM2.gif"></th> |
| + | </tr> |
| + | <tr> |
| + | <th>0μM</td> |
| + | <th>0.1μM</td> |
| + | <th>1μM</td> |
| + | <th>10μM</td> |
| + | </tr> |
| + | <tr> |
| + | <th colspan="4"><div align="center">Movie. 3 The formation process of SPOT in different concentration of rapamycin in one experiment. Higher concentration of rapamycin leads to faster formation of phase separation.</div></td> |
| + | </tr> |
| + | </table> |
| + | </div> |
| + | </div> |
| + | </div> |
| + | </div> |
| + | |
| + | |
| + | <div class="texttitle"><a id="Z"></a>Functions |
| + | </div> |
| + | |
| + | <hr style="border:2px dashed; height:2px" color="#1E90FF"> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <h3><a id="D1"></a>1.Spatial segregation and organization</h3> |
| </div> | | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | |
| <div class="content"> | | <div class="content"> |
− | <p>According to the results for the adsorption of 13nM uranyl, the polymer network exhibited a good ability in a simulated seawater environment. We could thus also look into other usage scenarios of Uranium Reaper, such as bio-mining and uranium enrichment.</p> | + | <p>The most basic function of a synthetic organelle is to form a segregated space, changing the position of a substance, and thereby causing a corresponding effect.</p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>The most basic function of a synthetic organelle is to form a segregated space, changing the position of a substance, and thereby causing a corresponding effect.</p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <h4>(1)Aggregation of target substances</h4> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>The components used to construct the synthetic organelles can condense via phase separation, resulting in different concentrations of their components in the synthetic organelles and the surrounding cytosol. If we control the expression of the SIM component (red fluorescence) in the synthetic organelle system composed of SUMO-SIM, we can regulate the distribution of the SUMO component (green fluorescence) in the cell. We used an inducible promoter to control the expression of the SIM component. When the SIM component was not expressed, the SUMO component was evenly distributed in the cells, and when the cells were treated with a sufficient concentration of doxorubicin, the SIM component was expressed. In that case, the expression is such that the SUMO components aggregate due to the formation of SPOT. |
| + | <br/> |
| + | <img src="https://static.igem.org/mediawiki/2018/1/15/T--Peking--Demof3.png"><div> |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;"> |
| + | Figure. 6A Construction of SUMO-yEGFP and SIM-mCherry to prove phase separation can be regulated at the level of gene expression. SUMO-yEGFP is under the control of a constitutive promoter and SIM-mCherry is under the control of Tet07 promoter, an inducible promoter, which can be induced by doxcycline(Dox). |
| + | <br/> |
| + | Figure. 6B Time-lapse fluorescence images of phase separation regulated at the level of gene expression. Before adding dox, only green fluorescence can be detected and it covers the entire cell. After adding dox for 5 hours, localization of red droplet and green droplet can be detected. Arrow points to localization of red and green droplets. Images were taken for ~ 7hr.Scalebar,30μm. |
| + | <br/> |
| + | Figure. 6C Fluorescence intensity of SUMO-yEGFP and SIM-mCherry, proportion of cells with SPOT. In a repeat experiment, after adding dox, red fluorescence intensity increases with time. What’s more, after the expression of SIM-mCherry, proportion of cells with SPOT increases well. |
| + | </figcaption ></p></div> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>Such condensation allows the components to perform their functions in a synthetic organelle without affecting the overall state of the cells, which allows some components that are toxic to the cells to function properly in the synthetic organelles without damaging the cells. As an example, high concentrations of rapamycin strongly inhibited the growth of yeast. However, in yeasts with synthetic organelles composed of FKBP/Frb, rapamycin can be used to induce the formation of synthetic organelles, and because of the presence of synthetic organelles, the yeast also gain the ability to resist rapamycin and grow normally in its presence.</p> |
| + | <img src="https://static.igem.org/mediawiki/2018/1/1a/T--Peking--DemoGrowth.png"> |
| + | |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;"> |
| + | Figure. 7 Growth curves of wild-type yeasts (black curve) and yeast strains with Ura3-FKBP-HOTag3 and PDH3-Frb-HOTag6 (red curve). They are measured after adding different concentration of rapamycin for 24 hours. Wild-type yeasts cannot grow and reproduce normally while engineered yeasts with FKBP-HOTag3 and Frb-HOTag6 can survive when exposed to rapamycin. |
| + | <br/> |
| + | <br/> |
| + | |
| + | </figcaption > |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <h4>(2)Organization hub</h4> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>A substance that does not participate in the construction of synthetic organelles can be aggregated within the synthetic organelles via diverse interactions.</p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>Using protein-protein interactions, the synthetic organelles can be treated as a platform for the organization of other substances, which makes the yeast with the synthetic organelles into a modular system for the regulation of the spatial distribution of substances. The anti-GFP nanobody is a protein that can specifically bind GFP with high affinity. We can fuse the protein to be controlled with the anti-GFP nanobody to aggregate it at the synthetic organelles.</p><img src="https://static.igem.org/mediawiki/2018/8/85/T--Peking--PS_2.png"><p> |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;"> |
| + | Figure .8A Fused function module and recruited function module. When function modules are recruited to SPOT, they may function well. |
| + | <br/> |
| + | Figure .8B Demonstration of nanobody system. Anti-GFP nanobody can combine to GFP and recruit the function module (replaced by CFP). The images merged well and confirmed that the design of nanobody system is feasible. |
| + | </figcaption ></p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>We verified this function by fusing CFP with the nanobody, and we observed the co-localization of the blue and green fluorescence, as expected.</p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>This system is modular and flexible. We can fuse almost any protein with the nanobody so that it can aggregate within the synthetic organelles. What’s more, this strategy avoids fusing proteins with the large system, which might result in the loss of function because of structural change. This system also has the potential to aggregate endogenous proteins and even small molecules by fusing the ligand of the substance with the nanobody as mediator. |
| + | </p> |
| </div> | | </div> |
| </div> | | </div> |
| | | |
| <div class="coll"> | | <div class="coll"> |
− | <div class="info">
| + | <div class="content"> |
− | <div class="ordi">4.</div> | + | <h3><a id="D2"></a>2.Sensor</h3> |
| </div> | | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | |
| <div class="content"> | | <div class="content"> |
− | <p>Exchange of the SUP module for other functional proteins. For example, we could integrate proteins which could bind other heavy metals such as mercury so that the polymer network could be used to treat other kinds of pollution as well.</p> | + | <p>Rapamycin can be used to induce the formation of the synthetic organelles. Thinking differently, rapamycin can be detected by the synthetic organelles. If the substance to be detected can bind with two proteins (homologous or heterologous) simultaneously, these proteins can be used as the interaction module to construct a synthetic organelle, and the presence of the detected molecule can consequently be shown by the formation of the synthetic organelles. As shown before, synthetic organelles arise when rapamycin is added, which means that the presence of synthetic organelles corresponds to the presence of rapamycin.</p> |
| </div> | | </div> |
| </div> | | </div> |
| | | |
| <div class="coll"> | | <div class="coll"> |
− | <div class="info"> | + | |
− | <div class="ordi">5.</div> | + | <div class="content"> |
| + | <p>Thus, we first verified this function with rapamycin. We cultured the yeast cells with different concentrations of rapamycin to make sure that rapamycin has enough time to diffuse into the calls and the formation of SPOT can reach the equilibrium state. We then observed the yeast cells under a microscope and made statistics on the proportion of the yeast with SPOT formation. The formation of the SPOT reflected the concentration of rapamycin well.</p> |
| </div> | | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | |
| <div class="content"> | | <div class="content"> |
− | <p>We could assemble enzyme systems behind the SpyTag backbone to create a production plant in vitro. In the protein polymeric network, the concentration of enzymes could be increased and the efficiency of biocatalysis may consequently also be enhanced.</p> | + | <p>Since rapamycin can be detected by SPOT, we went further and considered whether SPOT can also detect other molecules. Here we verified this potential by detecting ABA. Abscisic acid (ABA) is an important phytohormone that regulates plant stress responses. Proteins from the PYR-PYL-PCAR family were identified as ABA receptors. Upon binding to ABA, a PYL protein associates with type 2C protein phosphatases (PP2Cs) such as ABI1 and ABI2, inhibiting their activity.</p> |
| + | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>In our design, if we use PYL1/ABI1 as interaction modules, we will see the SPOT forming in the cell after ABA administration. However, we found the green fluorescence, which shows the location of PYL1, condensed into a granule like the SPOT before ABA administration. </p> |
| + | </div> |
| + | </div> |
| + | |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>We then manage to work out the reason. Previous structural and biochemical observations have provided insights into PYL-mediated ABA signaling, which can be explained by an efficacious model. In the absence of ABA signaling, PP2Cs are fully active and PYLs exist as inactive homodimers in cells, unable to bind or inhibit PP2Cs, mainly due to the incompatible conformation of the CL2loop. In response to ABA binding, the CL2 loop undergoes a conformational rearrangement to close over the ABA-binding pocket, which enables the interaction between PYLs and PP2Cs. </p> |
| </div> | | </div> |
| </div> | | </div> |
| | | |
| <div class="coll"> | | <div class="coll"> |
− | <div class="info"> | + | |
− | <div class="ordi">6.</div> | + | <div class="content"> |
| + | <p>This information explained this strange phenomenon, and also enabled a prediction. In the absence of ABA, SPOT formed only with PYL1 for the homodimers of PYL1. Thus, we can observe the green fluorescence in SPOT, but no red fluorescence colocalization. After we added ABA to the yeast, ABI1 entered the organelles through the interaction of ABI1 and PYL1, and we saw red aggregates colocalize with green aggregates in cells under the fluorescence microscope. We then verified this ABA sensor through the formation of red fluorescence. The pattern met the prediction perfectly and the system also detected ABA with a high sensitivity. .</p> |
| </div> | | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| <div class="content"> | | <div class="content"> |
− | <p>If we optimize the number of SpyTag or SpyCatcher modules per protein monomer, as well as the working concentrations of proteins, we may make protein-3D printing using the Spy Crosslinking Network come true.</p> | + | <p>This experiment also inspired us to design a new regulation method: controlling the location of one of the component instead of controlling the formation of SPOT. As the experiment demonstrated, new components can enter the original organelles and the time of occurrence can be regulated as it is inducer-mediated. This gave our designs and functions more possibilities. |
| + | Figure removed due to file size |
| + | Figure 6 Interaction of PYL and PP2C |
| + | </p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | |
| + | <div class="content"> |
| + | <p>As shown by the results, SPOT can be used to detect molecules in vivo. In contrast to traditional sensors, which rely on the expression of the reporter gene and have a delay of hours, this system has a much shorter reaction time of only minutes after the reagent is added to the yeast medium. The delay can be further shortened if the detected molecules are inside the cells. Thus, the synthetic organelles can function as a quick response sensor in vivo.</p> |
| + | <img src="https://static.igem.org/mediawiki/2018/9/90/T--Peking--demof4.png"> |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;"> |
| + | Figure. 9A Design of rapaSPOT. Rapamycin can induce phase separation process to form granules. |
| + | <br/> |
| + | Figure. 9B Resonse curve of rapamycin. SPOT shows high sensitivity to rapamycin and has great potential in sensor. |
| + | <br/> |
| + | Figure. 9C Design of a ABA sensor. ABA is a kind of plant hormone. By specific interaction module, SPOT can sense the presence of ABA. |
| + | <br/> |
| + | Figure. 9D The sensor function test of ABA sensor. In the presence of ABA, granules can be observed in both fluorescence channels. |
| + | </figcaption s> |
| + | </div> |
| + | </div> |
| + | |
| + | |
| + | |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | <br/> |
| + | <h3><a id="D3"></a>3.Reaction Hub</h3> |
| </div> | | </div> |
| </div> | | </div> |
− | | + | <div class="coll"> |
− | | + | <div class="content"> |
| + | <p>Our synthetic organelles are based on phase separation. Due to liquid-liquid phase separation inside cells, the synthetic organelles and the cytosol will form a boundary. This boundary has some special properties, such as absorbance effects. The synthetic organelles also condense many substances, which results in a different reaction environment and different concentration between the synthetic organelles and the cytosol. All these effects can affect the reaction rate and the direction of reaction in the synthetic organelles.</p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | <p>Since the effects of the synthetic organelles on different reactions can be diverse due to all the factors referred to above, we develop a model to find out the key factors that effect this process. The model suggests that a higher solubility of the substrate or intermediate in the droplet phase and a relatively large KM lead to higher reaction rate. ( Please read the model for more details)</p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | <p>According to the conclusion given by the model, we examined the production of β-carotene as a first step. The intermediates of this pathway are hydrophobic and the reaction have a large KM, we suppose SPOT might increase the produce of β-carotene. What’s more, the β-carotene production pathway is widely used in biology. It is robust and its activity is directly observable since β-carotene is orange. We fused the three enzymes that produce β-carotene into the synthetic organelles. In the presence of rapamycin, they can condense into aggregates.</p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | <p>As the result shows, after adding rapamycin, the yeast accumulate more β-carotene and the color become redder.</p><div align="center"> |
| + | <p>To demonstrate this increasing quantitatively, we extract β-carotene from the yeast and measure the concentration with HPLC (High Performance Liquid Chromatography). HPLC result also show an increasing after adding rapamycin.</p></div> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | <p>Here we already demonstrate that SPOT can regulate the reaction rate and further regulate the produce of the pathway. However, there are still too many phenomes that we can not explain in a near future. Through more work on different metabolic pathway, we may one day can using SPOT to control the metabolism in cell.</p> |
| + | </div> |
| + | </div> |
| + | <div class="coll"> |
| + | <div class="content"> |
| + | <div align="center"> |
| + | <img src="https://static.igem.org/mediawiki/2018/4/45/T--Peking--figadd.png"> |
| + | </div> |
| + | <div class="coll"> |
| + | <figcaption style="text-align:justify; text-justify:inter-ideograph;"> |
| + | Fig. 10A β-carotene production pathway widely used in biology. <br/> |
| + | Fig. 10B Design of SPOT producing carotene. |
| + | <br/> |
| + | Fig. 10C fluorescence images and carotene production result after rendered by rapamycin for 36h. |
| + | <br/> |
| + | Fig. 10D HPLC result of carotene production after 48h. |
| + | <br/> |
| + | Fig. 10E β-carotene production for the same amount of yeasts after 48h. The results are calculated by dividing peak area over the mass of yeasts in each group and then normalized by the first group.</div> |
| + | <br/> |
| + | </div> |
| + | </figcaption > |
| + | </div> |
| + | |
| + | |
| | | |
| </div><!--9 columns end--> | | </div><!--9 columns end--> |
Line 510: |
Line 890: |
| | | |
| | | |
− | <!-- footer============================================================================== -->
| + | <!-- footer============================================================================== --> |
| <style> | | <style> |
| footer .copyright span:before { | | footer .copyright span:before { |
Line 526: |
Line 906: |
| </style> | | </style> |
| <footer id="page-footer"> | | <footer id="page-footer"> |
| + | <footer id="page-footer"> |
| + | <div class="row,row1"> |
| + | <ul class="footer-social"> |
| + | <li class="col-md-6" id="PKU-administration" style="margin-bottom:25px;max-width:300px"> |
| + | <a href="http://dean.pku.edu.cn/pkudean/index.html"><img src="https://static.igem.org/mediawiki/2018/7/7a/T--Peking--images_PKU_Administration_logo.png"></a> |
| + | </li> |
| + | <li class="col-md-6" id="PKU-SLS" style="margin-bottom:25px;max-width:300px"> |
| + | <a href="http://www.bio.pku.edu.cn/"><img src="https://static.igem.org/mediawiki/2018/0/04/T--Peking--images_PKU_SLS_logo.png"></a> |
| + | </li> |
| + | |
| + | <li class="col-md-6" id="PKU-CQB" style="margin-bottom:25px;max-width:300px"> |
| + | <a href="http://cqb.pku.edu.cn/en/"><img src="https://static.igem.org/mediawiki/2018/e/e1/T--Peking--images_PKU_CQB_logo.png"></a> |
| + | </li> |
| + | |
| + | </ul> |
| + | </div> |
| <div class="row"> | | <div class="row"> |
| <div class="twelve columns" > | | <div class="twelve columns" > |
| <ul class="copyright"> | | <ul class="copyright"> |
| <!--<li>© 2014 Sparrow</li> --> | | <!--<li>© 2014 Sparrow</li> --> |
− | <li><a href="2016.igem.org/Team:Peking">Home</a> <a href="mailto:pkuigem2016@126.com">Contact</a></li> | + | <li><a href="https://2018.igem.org/Team:Peking">Home</a> <a href="mailto:indigomad@pku.edu.cn">Contact</a></li> |
− | <span> ©2016 PEKING IGEM. All Rights Reserved.</span> | + | <span> ©2018 PEKING IGEM. All Rights Reserved.</span> |
| <li><a href="http://getbootstrap.com/2.3.2/">Based on Bootstrap</a></li> | | <li><a href="http://getbootstrap.com/2.3.2/">Based on Bootstrap</a></li> |
| </ul> | | </ul> |
Line 537: |
Line 933: |
| <div id="go-top" style="display: block;"><a title="Back to Top" href="#">Go To Top</a></div> | | <div id="go-top" style="display: block;"><a title="Back to Top" href="#">Go To Top</a></div> |
| </div> | | </div> |
− | </footer> <!-- Footer End-->
| + | |
− |
| + | |
− |
| + | <!-- Footer End--> |
− | <!-- Java Script======================================================================= -->
| + | |
− | <script>window.jQuery || document.write('<script src="https://2016.igem.org/Template:Peking/Javascript/jquery_1_10_2_min?action=raw&ctype=text/javascript"><\/script>')</script>
| + | |
− | <script type="text/javascript" src="https://2016.igem.org/Template:Peking/Javascript/jquery_migrate_1_2_1_min?action=raw&ctype=text/javascript"></script>
| + | <!-- Java Script======================================================================= --> |
− |
| + | <script>window.jQuery || document.write('<script src="https://2018.igem.org/Template:Peking/Javascript/jquery_1_10_2_min?action=raw&ctype=text/javascript"><\/script>')</script> |
− | <script src="https://2016.igem.org/Template:Peking/Javascript/jquery_flexslider?action=raw&ctype=text/javascript"></script>
| + | <script type="text/javascript" src="https://2018.igem.org/Template:Peking/Javascript/jquery_migrate_1_2_1_min?action=raw&ctype=text/javascript"></script> |
− | <script src="https://2016.igem.org/Template:Peking/Javascript/doubleaptogo?action=raw&ctype=text/javascript"></script>
| + | |
− | <script src="https://2016.igem.org/Template:Peking/Javascript/init?action=raw&ctype=text/javascript"></script>
| + | <script src="https://2018.igem.org/Template:Peking/Javascript/jquery_flexslider?action=raw&ctype=text/javascript"></script> |
− |
| + | <script src="https://2018.igem.org/Template:Peking/Javascript/doubleaptogo?action=raw&ctype=text/javascript"></script> |
− |
| + | <script src="https://2018.igem.org/Template:Peking/Javascript/init?action=raw&ctype=text/javascript"></script> |
− | <!--quotations from black: start-->
| + | |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/jquery?action=raw&ctype=text/javascript"></script>
| + | <!--quotations from flexslider: start--> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/jquery_sticky?action=raw&ctype=text/javascript"></script>
| + | <script src='https://2018.igem.org/Template:Peking/Javascript/modernizr_js?action=raw&ctype=text/javascript'></script> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/jquery_easing_1_3_pack?action=raw&ctype=text/javascript"></script>
| + | <script type='text/javascript' src='https://2018.igem.org/Template:Peking/Javascript/fjquery_polaroid?action=raw&ctype=text/javascript'></script> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/bootstrap_min?action=raw&ctype=text/javascript"></script>
| + | <script type='text/javascript' src='https://2018.igem.org/Template:Peking/Javascript/fjquery_easing?action=raw&ctype=text/javascript'></script> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/jquery_patallax_1_1_3?action=raw&ctype=text/javascript"></script>
| + | <script type='text/javascript' src='https://2018.igem.org/Template:Peking/Javascript/fjquery_transform_0_8_0_min?action=raw&ctype=text/javascript'></script> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/appear?action=raw&ctype=text/javascript"></script>
| + | <script type='text/javascript' src='https://2018.igem.org/Template:Peking/Javascript/fjquery_preloader?action=raw&ctype=text/javascript'></script> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/modernizr?action=raw&ctype=text/javascript"></script>
| + | <!--quotations from flexslider: end--> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/jquery_prettyPhoto?action=raw&ctype=text/javascript"></script>
| + | |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/isotope?action=raw&ctype=text/javascript"></script>
| + | <!--quotations from black: start--> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/jquery_bxslider_min?action=raw&ctype=text/javascript"></script>
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/jquery?action=raw&ctype=text/javascript"></script> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/jquery_cycle_all?action=raw&ctype=text/javascript" ></script>
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/jquery_sticky?action=raw&ctype=text/javascript"></script> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/jquery_maximage?action=raw&ctype=text/javascript"></script>
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/jquery_easing_1_3_pack?action=raw&ctype=text/javascript"></script> |
− | <script type='text/javascript' src="https://2016.igem.org/Template:Peking/Javascript/scripts?action=raw&ctype=text/javascript "></script>
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/bootstrap_min?action=raw&ctype=text/javascript"></script> |
− | <!--quotations from black: end-->
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/jquery_patallax_1_1_3?action=raw&ctype=text/javascript"></script> |
− | </body>
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/appear?action=raw&ctype=text/javascript"></script> |
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/modernizr?action=raw&ctype=text/javascript"></script> |
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/jquery_prettyPhoto?action=raw&ctype=text/javascript"></script> |
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/isotope?action=raw&ctype=text/javascript"></script> |
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/jquery_bxslider_min?action=raw&ctype=text/javascript"></script> |
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/jquery_cycle_all?action=raw&ctype=text/javascript" ></script> |
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/jquery_maximage?action=raw&ctype=text/javascript"></script> |
| + | <script type='text/javascript' src="https://2018.igem.org/Template:Peking/Javascript/scripts?action=raw&ctype=text/javascript "></script> |
| + | <!--quotations from black: end--> |
| + | |
| + | |
| + | </body> |
| </html> | | </html> |